Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women with Polycystic Ovary Syndrome

Keyphrases

• Genetic Variation 100%
• Polycystic Ovary Syndrome 100%
• Phytohormone Signaling 100%
• Anti-Mllerian Hormone 100%
• Functional Genetics 100%
• Functional Variants 18%
• Genetic Variants 9%
• Endocrine Disorders 9%
• In Vitro Assay 9%
• Etiology 9%
• Coding Region 9%
• Population-based 9%
• 2 Receptor 9%
• In Silico 9%
• Epigenetic Modification 9%
• Hyperandrogenism 9%
• Regulatory Region 9%
• Specific Types 9%
• Signaling Activity 9%
• Transcriptional Repression 9%
• Polycystic Ovary 9%
• Steroidogenesis 9%
• Prediction Tool 9%
• Functional Assessment 9%
• Dual-luciferase Reporter Assay 9%
• Irregular Menses 9%
• Pathogenic Variants 9%
• Targeted Resequencing 9%

Biochemistry, Genetics and Molecular Biology

• Genetic Divergence 100%
• Genetic Variation 100%
• Menstruation 50%
• Epigenetic Modification 50%
• Regulatory Region 50%
• Luciferase 50%
• Steroid Biosynthesis 50%

Medicine and Dentistry

• Polycystic Ovary Syndrome 100%
• Genetic Variation 100%
• In Vitro 8%
• Cell Signaling Pathway 8%
• Receptor 8%
• In Silico 8%
• Hyperandrogenism 8%
• Regulatory Region 8%
• Menstruation 8%
• Steroidogenesis 8%
• Endocrine Disease 8%
• Luciferase Assay 8%
• Epigenetic Modification 8%
• Hormone Signaling 8%
• CYP17A1 8%